Pelthos Therapeutics (PTHS) Non-Current Deffered Revenue (2025 - 2026)

Pelthos Therapeutics' Non-Current Deffered Revenue history runs 1 years deep, the most recent figure standing at $1.3 million for Q4 2025.

• In Q4 2025, Non-Current Deffered Revenue changed N/A year-over-year to $1.3 million; the TTM figure through Dec 2025 stood at $1.3 million (changed N/A YoY), while the FY2025 annual figure was $1.3 million, changed N/A from the prior year.
• Non-Current Deffered Revenue for Q4 2025 stood at $1.3 million.
• The five-year high for Non-Current Deffered Revenue was $1.3 million in Q4 2025, with the low at $1.3 million in Q4 2025.